Search

Author/Creator Madison, Russell

1. Amivantamab (JNJ-61186372) induces clinical, biochemical, molecular, and radiographic response in a treatment-refractory NSCLC patient harboring amplified triple EGFR mutations (L858R/ T790M/G796S) in cis. (February 2022)

Authors:
Nagasaka, Misako; Balmanoukian, Ani S.; Madison, Russell; Zhang, Shannon S.; Klempner, Samuel J.; Ou, Sai-Hong Ignatius
Journal:
Lung cancer
Issue:
Volume 164(2022)
Page Start:
52
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Characterization of Non–Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment Patterns. (2021)

Authors:
Lee, Jessica K.; Madison, Russell; Classon, Anthony; Gjoerup, Ole; Rosenzweig, Mark; Frampton, Garrett M.; Alexander, Brian M.; Oxnard, Geoffrey R.; Venstrom, Jeffrey M.; Awad, Mark M.; Schrock, Alexa B.
Journal:
JCO precision oncology
Issue:
Volume 5(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Characterization of Non–Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment Patterns. (25th August 2021)

Authors:
Lee, Jessica K.; Madison, Russell; Classon, Anthony; Gjoerup, Ole; Rosenzweig, Mark; Frampton, Garrett M.; Alexander, Brian M.; Oxnard, Geoffrey R.; Venstrom, Jeffrey M.; Awad, Mark M.; Schrock, Alexa B.
Journal:
JCO precision oncology
Issue:
Volume 5(2021)
Page Start:
1354
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Clinicopathologic Features of a Series of Primary Renal CIC-rearranged Sarcomas With Comprehensive Molecular Analysis. (October 2018)

Authors:
Mangray, Shamlal; Kelly, David R.; LeGuellec, Sophie; Fridman, Eddie; Aggarwal, Sangeeta; Shago, Mary; Matoso, Andres; Madison, Russell; Pramanik, Sharmila; Zhong, Shan; Li, Rong; Lombardo, Kara A.; Cramer, Stuart; Pressey, Joseph; Ross, Jeffrey S.; Corona, Robert J.; Bratslavsky, Gennady; Argani...
Journal:
American journal of surgical pathology
Issue:
Volume 42:Number 10(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Clinicopathologic, genomic and protein expression characterization of 356 ROS1 fusion driven solid tumors cases. Issue 7 (23rd December 2020)

Authors:
Huang, Richard S. P.; Haberberger, James; Sokol, Ethan; Schrock, Alexa B.; Danziger, Natalie; Madison, Russell; Trabucco, Sally; Jin, Dexter; Pavlick, Dean; Ramanan, Vivek; Hole, Kanchan; McGregor, Kimberly; Venstrom, Jeffrey; Ross, Jeffrey S.
Journal:
International journal of cancer
Issue:
Volume 148:Issue 7(2021)
Page Start:
1778
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. FGFR2‐Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape. (27th June 2019)

Authors:
Klempner, Samuel J.; Madison, Russell; Pujara, Vivek; Ross, Jeffrey S.; Miller, Vincent A.; Ali, Siraj M.; Schrock, Alexa B.; Kim, Seung Tae; Maron, Steven B.; Dayyani, Farshid; Catenacci, Daniel V.T.; Lee, Jeeyun; Chao, Joseph
Journal:
Oncologist
Issue:
Volume 24:Number 11(2019)
Page Start:
1462
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy. (29th October 2018)

Authors:
Kang, Hyunseok; Pettinga, Dean; Schubert, Adrian D.; Ladenson, Paul W.; Ball, Douglas W.; Chung, Jon H.; Schrock, Alexa B.; Madison, Russell; Frampton, Garrett M.; Stephens, Phil J.; Ross, Jeffrey S.; Miller, Vincent A.; Ali, Siraj M.
Journal:
Oncologist
Issue:
Volume 24:Number 6(2019)
Page Start:
791
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer. (9th June 2020)

Authors:
Bandini, Marco; Ross, Jeffrey S; Raggi, Daniele; Gallina, Andrea; Colecchia, Maurizio; Lucianò, Roberta; Giannatempo, Patrizia; Farè, Elena; Pederzoli, Filippo; Bianchi, Marco; Colombo, Renzo; Gandaglia, Giorgio; Fossati, Nicola; Marandino, Laura; Capitanio, Umberto; Deho', Federico; Ali, Siraj M...
Journal:
Journal of the National Cancer Institute
Issue:
Volume 113:Number 1(2021)
Page Start:
48
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. RAS Amplification as a Negative Predictor of Benefit from Anti-EGFR–Containing Therapy Regimens in Metastatic Colorectal Cancer. (10th February 2021)

Authors:
Schrock, Alexa B.; Lee, Jessica K.; Sandhu, Jaideep; Madison, Russell; Cho-Phan, Cheryl; Snider, Jeremy W.; Castellanos, Emily; Venstrom, Jeffrey M.; Fakih, Marwan
Journal:
Oncologist
Issue:
Volume 26:Number 6(2021)
Page Start:
469
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. RAS Amplification as a Negative Predictor of Benefit from Anti‐EGFR–Containing Therapy Regimens in Metastatic Colorectal Cancer. (10th February 2021)

Authors:
Schrock, Alexa B.; Lee, Jessica K.; Sandhu, Jaideep; Madison, Russell; Cho‐Phan, Cheryl; Snider, Jeremy W.; Castellanos, Emily; Venstrom, Jeffrey M.; Fakih, Marwan
Journal:
Oncologist
Issue:
Volume 26:Number 6(2021)
Page Start:
469
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗